Abstract:
본 발명은 갱년기 이후 여성에서 유발되는 피부의 주름, 탄력 및 피부 보습을 개선시킬 수 있는 외용제 조성물에 관한 것으로, 보다 상세하게는 여성호르몬과 유사작용을 하는 피토에스트로젠(phytoestrogen) 성분을 다량 함유하고 있는 대두배아 이소플라본 어글리콘(Soybean Germ Isoflavone Agylcone), 석류 추출물 (Pomegranate Extract), 및 세코이소라리시레시놀(Secoisolariciresinol)을 혼합하여 제조한 'IB complex(Inner Balance Complex)'를 함유하여 피부 주름의 개선 및 피부 탄력 증진에 효과가 우수한 외용제 조성물에 관한 것이다. IB complex * 대두배아 이소플라본 어글리콘 * 석류 추출물 * 세코이소라리시레시놀 * 피부 주름 개선 * 피부 탄력 증진 * 피부 보습 증진
Abstract:
A skin external composition comprising a cathepsin G inhibitor is provided to prevent an adhesion protein from being degraded by intrinsic aging and photo-aging, reduce the production of metalloproteinase and inhibit the activity of metalloproteinase, thereby being more potent anti-aging substance than existing anti-aging substances. A method for screening anti-aging materials is provided to develop the anti-aging materials which effectively inhibit the quantitative and qualitative increase of metalloproteinase, resulting from the degradation of an adhesion protein by cathepsin G in skin cells without direct UV irradiation. A skin external composition for preventing skin aging comprises 0.01-10 wt% a cathepsin G inhibitor as an effective ingredient, wherein the cathepsin G inhibitor is at least one selected from the group consisting of compounds represented by formulae(1) to (4). The composition is formulated into skin lotion, astringent lotion, milk lotion, nourishing cream, essence, massage cream, eye cream, pack, body lotion, body cream, body oil or body essence. A method for screening an anti-aging material comprises the steps of: (a) adding an anti-aging candidate material to a substrate in the presence of cathepsin G enzyme; and (b) measuring the inhibition of activity of the cathepsin G enzyme. Further, the measure of the inhibition of activity of the cathepsin G enzyme is performed by measuring a concentration of a produced metalloprotease.
Abstract:
Provided is a 3,5-dihydroxybenzoic acid derivative, which shows an elastase inhibitory effect and an excellent effect of scavenging free radicals generated by UV irradiation, has an excellent anti-aging effect, and is useful for an anti-aging cosmetic composition. The 3,5-dihydroxybenzoic acid derivative is a compound represented by a formula 1, substituted with hydroxyl groups at 3,5-position thereof and the amide group being substituted with a bulky substituent. The 3,5-dihydroxybenzoic acid derivative is obtained by the method comprising the steps of: (A) reacting 3,5-dihydroxybenzoic acid with acetic anhydride to form 3,5-diacetyloxybenzoic acid; (B) forming an amide compound from the 3,5-diacetyloxybenzoic acid by using ethyl chloroformate and an oleophilic group; and (C) hydrolyzing the acetyl group of the amide compound to provide a 3,5-dihydroxybenzoic acid derivative.
Abstract:
본 발명은 하기 화학식 1로 표시되는 히드록삼산(Hydroxamic acid) 유도체 및 그 제조방법에 관한 것이다: [화학식 1]
상기 식 중에서, R 1 및 R 2 는 수소, C 1-10 의 알킬 또는 C 3-6 의 알킬 고리이고; R 3 는 CONH, NHCO, CONR 5 , 또는 NR 5 CO 이며, 이때, R 5 는 수소 또는 C 1-10 의 알킬이고; 및 R 4 는 -(CH)n- 이며, n = 0, 1이다. 또한 본 발명은 상기 화학식 1의 히드록삼산 유도체를 유효성분으로 함유하는 피부노화 방지용 피부 외용제 조성물에 관한 것이다. 레티노이드 * 레티노익산 수용체 * 히드록삼산 유도체 * 항노화 * 콜라겐 * 엘라스틴 * 콜라게나아제 발현억제 * 엘라스테이즈 발현억제 * 탄력 개선 * 피부 외용제
Abstract:
PURPOSE: Provided is a composition for skin external application containing the IB complex which is composed of soybean germ isoflavone aglycone, pomegranate extract and secoisolariciresinol, thereby improving skin wrinkle and enhancing elasticity. CONSTITUTION: The composition for skin external application is characterized by containing 0.001-20 wt.% of soybean germ isoflavone aglycone, 0.001-20 wt.% of pomegranate extract and 0.001-20 wt.% of secoisolariciresinol, based on the total weight of the composition. The composition has excellent effect on improvement of skin wrinkle and enhancement of elasticity.
Abstract:
The present invention relates to a method for evaluating damage of a skin barrier using a biomarker, and more specifically, to a method for evaluating damage of a skin barrier, comprising collecting dead skin cells or sebum to measure a biomarker therefrom. In addition, the present invention relates to a kit for evaluating damage of a skin barrier by collecting dead skin cells or sebum to measure a biomarker therefrom. The method and kit for evaluating damage of a skin barrier are used to easily and rapidly evaluate the damage of the skin barrier, thereby promptly and conveniently determining skin diseases such as atopy and psoriasis and the presence or absence of bacterial infection, and thus can diagnose the skin conditions.